Eversept Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Sell |
640,673
-301,781
| -32% | -$727K | 0.14% | 55 |
|
|
2025
Q1 | $2.08M | Buy |
+942,454
| New | +$2.08M | 0.21% | 42 |
|
|
2024
Q4 | – | Sell |
-336,966
| Closed | -$2.8M | – | 73 |
|
|
2024
Q3 | $2.8M | Buy |
+336,966
| New | +$2.8M | 0.19% | 52 |
|
|
2023
Q4 | – | Sell |
-452,323
| Closed | -$4.52M | – | 64 |
|
|
2023
Q3 | $4.52M | Buy |
+452,323
| New | +$4.52M | 0.38% | 40 |
|
|
2022
Q4 | – | Sell |
-160,000
| Closed | -$4.08M | – | 70 |
|
|
2022
Q3 | $4.08M | Sell |
160,000
-265,364
| -62% | -$6.77M | 0.35% | 33 |
|
|
2022
Q2 | $12.1M | Buy |
+425,364
| New | +$12.1M | 0.86% | 28 |
|
|
2022
Q1 | – | Sell |
-87,795
| Closed | -$3.68M | – | 90 |
|
|
2021
Q4 | $3.68M | Sell |
87,795
-240,015
| -73% | -$10.1M | 0.24% | 56 |
|
|
2021
Q3 | $16.1M | Buy |
327,810
+252,810
| +337% | +$12.4M | 1.11% | 22 |
|
|
2021
Q2 | $3.13M | Buy |
+75,000
| New | +$3.13M | 0.21% | 46 |
|